Indefinite Delivery Contract SPE2DX16D9945

The Indefinite Delivery Contract (IDC) SPE2DX16D9945 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The single-award IDC, valued at up to $4,999,999.99, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined, comprehensive contracting mechanism.

The DLA Troop Support Medical, a critical component of the Defense Logistics Agency, is responsible for managing the supply chain and procurement of medical materials for the U.S. Department of Defense. The IDC awarded to Amerisourcebergen serves as the primary vehicle for the DLA to obtain a wide variety of pharmaceutical and medical commodities required to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The contract's broad scope and lack of set-aside requirements reflect Amerisourcebergen's established position as a leading supplier of pharmaceutical and medical products to the federal government.